FDA Investigator: Stacey S. Degarmo
- Stacey S. Degarmo first started conducting FDA inspections in 2009, with the last inspection in 2016. Over that time, Stacey S. Degarmo has conducted 90 inspections at 74 companies across 77 sites.
Get Stacey Degarmo's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Anderson Holdings, Nashua | February 2016
Available Now - $199
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Rhodes Technologies, Coventry | August 2014
Available Now - $199
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Cubist Pharmaceuticals, Lexington | July 2014
Available Now - $199
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Precise Packaging, Fall River | April 2014
Available Now - $199
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Central Admixture Pharmacy Services, Woburn | 2013
Available Now - $199
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Wyeth BioPharma Division of Wyeth Pharmaceuticals, Inc., Andover | 2016
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Lonza Biologics, Inc., Portsmouth | 2016
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Albany Molecular Research, Inc., Burlington | 2016
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Avista Pharma Solutions, Inc., Agawam | 2016
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 AstraZeneca LP, Westborough | 2016
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Cambridge Isotope Laboratories, Inc., Andover | 2016
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Bedford Pharmacy, Bedford | 2015
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Dyax Corp., Burlington | 2015
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 AbbVie Research Bioresearch Center, Worcester | 2015
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Rotech Healthcare Inc.d/b/a/ First Community Care of Niagara, Woburn | 2015
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Lyophilization Services of New Enlgand, Inc., Bedford | 2015
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Peptisyntha S.A., Brussels | 2015
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Peptisyntha S.A., Bruxelles | 2015
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Sunovion Pharmaceuticals Inc., Marlborough | 2015
Out-of-stock
Stacey S. Degarmo
Human Drug Form 483
FDA 483 Anika Therapeutics, Inc., Bedford | 2014
Out-of-stock
Stacey S. Degarmo
Animal Drugs & Feed Form 483
Co-Investigators (32)
- Sean R. Marcsisin, FDA Investigator
- Katherine D. Adams, FDA Investigator
- John P. Mistler, FDA Investigator
- Dien N. Nguyen, FDA Investigator
- Richard B. McAroy, FDA Investigator
- Deborah J. Parris, FDA Investigator
- Erik W. Koester, FDA Investigator
- Cynthia A. Palmer, FDA Investigator
- Jayaleka J. Amarasinghe, FDA Investigator
- Arie Menachem, FDA Investigator
- Mary-Jeanet McGarry, FDA Investigator
- Ramon E. Martinez, FDA Investigator
- Camerson E. Moore, FDA Investigator
- Stephen C. Smith, FDA Investigator
- Abby E. Pelletier, FDA Investigator
- Kenneth H. Williams, FDA Investigator
- Jennifer T. Szymanski, FDA Investigator
- Philip Kreiter, FDA Investigator
- Debra M. Emerson, FDA Investigator
- Rory Geyer, FDA Investigator
- Almaris N. Alonso, FDA Investigator
- Thomas W. Nerney, FDA Investigator
- Amy C. Jordan, FDA Investigator
- Megan A. Haggerty, FDA Investigator
- Justine M. Corson, FDA Consumer Safety Officer
- Aireen V. Mendoza, FDA Investigator
- Thomas J. Arista, FDA Investigator
- Alice C. Silva, FDA Investigator
- Margaret E. Walsh, FDA Investigator
- Leo B. Zadecky, FDA Investigator
- Louis Christy, FDA Investigator
- Kathleen E. McAfoose, FDA Investigator